Search Results - "Eng, Cathy"
-
1
The Evolving Role of Monoclonal Antibodies in Colorectal Cancer: Early Presumptions and Impact on Clinical Trial Development
Published in The oncologist (Dayton, Ohio) (01-01-2010)“…Targeted biologic agents have an established role in treating metastatic colorectal cancer (mCRC). Bevacizumab, a recombinant monoclonal antibody against the…”
Get full text
Journal Article -
2
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group
Published in The oncologist (Dayton, Ohio) (01-06-2020)“…The outbreak of coronavirus disease 2019 (COVID‐19) has rapidly spread globally since being identified as a public health emergency of major international…”
Get full text
Journal Article -
3
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Published in Journal of clinical oncology (20-01-2023)“…To develop recommendations for treatment of patients with metastatic colorectal cancer (mCRC). ASCO convened an Expert Panel to conduct a systematic review of…”
Get full text
Journal Article -
4
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Published in Journal of clinical oncology (01-10-2017)“…Purpose To update the ASCO guideline for antiemetics in oncology. Methods ASCO convened an Expert Panel and conducted a systematic review of the medical…”
Get full text
Journal Article -
5
Antiemetics: ASCO Guideline Update
Published in Journal of clinical oncology (20-08-2020)“…To update the guideline to include new anticancer agents, antiemetics, and antiemetic regimens and to provide recommendations on the use of dexamethasone as a…”
Get full text
Journal Article -
6
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
Published in The lancet oncology (01-04-2017)“…Summary Background Squamous cell carcinoma of the anal canal (SCCA) is a rare malignancy associated with infection by human papillomavirus (HPV). No consensus…”
Get full text
Journal Article -
7
Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer
Published in Clinical cancer research (01-10-2019)“…The incidence rates of colorectal cancers are increasing in young adults. The objective of this study was to investigate genomic differences between tumor…”
Get full text
Journal Article -
8
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes
Published in Clinical cancer research (01-03-2018)“…Colorectal cancers are classified as right/left-sided based on whether they occur before/after the splenic flexure, with established differences in molecular…”
Get full text
Journal Article -
9
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Published in Journal of clinical oncology (01-08-2009)“…Fluorouracil/leucovorin as the sole therapy for metastatic colorectal cancer (CRC) provides an overall survival of 8 to 12 months. With an increase in surgical…”
Get full text
Journal Article -
10
Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer
Published in Journal of clinical oncology (20-05-2012)“…Neoadjuvant chemoradiotherapy for rectal cancer is associated with improved local control and may result in complete tumor response. Associations between tumor…”
Get full text
Journal Article -
11
High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome
Published in Journal of clinical oncology (10-03-2011)“…Prolonged survival after two-stage resection (TSR) of advanced colorectal liver metastases (CLM) may be the result of selection of best responders to…”
Get full text
Journal Article -
12
Randomized controlled trial of neurofeedback on chemotherapy‐induced peripheral neuropathy: A pilot study
Published in Cancer (01-06-2017)“…BACKGROUND Chemotherapy‐induced peripheral neuropathy (CIPN) is a significant problem for cancer patients, and there are limited treatment options for this…”
Get full text
Journal Article -
13
Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005
Published in American journal of clinical oncology (01-12-2011)“…The objectives of the current study were to examine the trends in incidence rates of subsite-specific colorectal cancer at all stages in a large US population…”
Get full text
Journal Article -
14
Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer
Published in Journal of clinical oncology (10-08-2017)“…Purpose After preoperative chemoradiotherapy followed by total mesorectal excision for locally advanced rectal cancer, patients who experience local or…”
Get full text
Journal Article -
15
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Published in Journal of clinical oncology (20-01-2010)“…We investigated the efficacy of fluorouracil (FU), leucovorin, irinotecan, and bevacizumab (FOLFIRI + B) in a phase II trial in patients previously untreated…”
Get full text
Journal Article -
16
Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer
Published in CA: a cancer journal for clinicians (01-09-2023)“…The American Joint Committee on Cancer (AJCC) staging system for all cancer sites, including anal cancer, is the standard for cancer staging in the United…”
Get full text
Journal Article -
17
Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal
Published in Molecular cancer research (01-11-2017)“…Squamous cell carcinoma of the anal canal (SCCA) is a rare gastrointestinal malignancy with an increasing annual incidence globally. The majority of cases are…”
Get full text
Journal Article -
18
Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up
Published in Annals of surgical oncology (01-01-2017)“…Background Low-grade appendiceal mucinous neoplasm of uncertain malignant potential are poorly understood lesions characterized by extraluminal mucin or…”
Get full text
Journal Article -
19
Global and targeted serum metabolic profiling of colorectal cancer progression
Published in Cancer (15-10-2017)“…BACKGROUND Patients with colorectal adenoma polyps (PLPs) are at higher risk for developing colorectal cancer (CRC). However, the development of improved and…”
Get full text
Journal Article -
20
Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer
Published in International journal of radiation oncology, biology, physics (01-03-2010)“…Purpose We designed this Phase II trial to assess the efficacy and safety of the addition of bevacizumab to concurrent neoadjuvant capecitabine-based…”
Get full text
Journal Article